Singapore markets closed

Motus GI Holdings, Inc. (MOTS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4161-0.0157 (-3.64%)
At close: 04:00PM EDT
0.4410 +0.02 (+5.98%)
After hours: 06:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4318
Open0.4530
Bid0.4050 x 100
Ask0.4640 x 100
Day's range0.4100 - 0.4530
52-week range0.4010 - 23.4000
Volume69,176
Avg. volume1,705,698
Market cap2.094M
Beta (5Y monthly)1.34
PE ratio (TTM)N/A
EPS (TTM)-15.8900
Earnings date08 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.30
  • GlobeNewswire

    Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

    Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process to seek strategic partnerships aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder valueRecent exercise of certain outstanding warrants provided infusion of $2.7M in gross proceeds to the Company, which extended its cash runway into the fourth quarter of 2024 FO

  • GlobeNewswire

    Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds

    FORT LAUDERDALE, Fla., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus” or “the Company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has entered into a definitive agreement for the immediate exercise of an outstanding Series B common stock purchase warrant held by an institutional investor to purchase an aggregate of 2,933,334 shares of the Company’s common stock for gross proceeds to the Comp

  • GlobeNewswire

    Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

    FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the “Company”) (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent (patent # 11904085) titled, “Colon Cleaning System with Automatic Self-Purging Feature.” “We are pleased to announce further strengthening our IP portfolio in the U.S. This latest patent c